ECRM_1170x120_8-1-17

Flonase, Weather Network team on Allergy Outlook

Print Friendly, PDF & Email
OAKVILLE, Ontario — The Weather Network and French counterpart MétéoMédia have introduced the Allergy Outlook report in partnership with GSK Consumer Healthcare’s Flonase Allergy Relief brand.

The Allergy Outlook provides timely information on mold, pollen and air quality levels. Launching initially in British Columbia, where seasonal allergies typically begin in February, the Allergy Outlook is slated to be fully available across Canada in March, just as seasonal allergies are starting to emerge with the spring weather, The Weather Network said.

Allergy Outlook_Flonase_The Weather Network

The Allergy Outlook gives a visual look at the risk of allergy symptoms based on daily pollen, mold and air quality data for locations across Canada.

Available at theweathernetwork.com, meteomedia.com and Flonase.ca, the Allergy Outlook gives a visual look at the risk of allergy symptoms based on daily pollen, mold and air quality data for nearly 11,000 locations across Canada.

Air quality indicators will be available for the current day with a rating of low, medium or high. Pollen and mold levels will include ratings for the current day and up to 48 hours in advance with ratings of low, medium, high and very high.

“We know that Canadian allergy sufferers continue to be frustrated by their allergy symptoms. A daily report providing information that allows allergy sufferers to successfully plan their days and do more of the things they enjoy is a great way to help them,” stated Babita Bhattal, director of marketing for GSK Consumer Healthcare. “Flonase Allergy Relief is partnering with The Weather Network and MétéoMédia to bring Canadians a way to really get ahead of their allergies.”

Flonase Allergy Relief, approved for over-the-counter use in Canada at the end of August and released earlier this year, the first and only nonprescription nasal spray for relief of eye-related and nasal allergy symptoms caused by seasonal and year-round allergens, including pollen, mold, dust and pets. It provides 24 hour, non-drowsy allergy relief of sneezing, itchy nose and throat, runny nose and itchy, watery eyes, nasal congestion and sinus pain and pressure.

The Weather Network and MétéoMédia, part of Pelmorex Media Inc., also are releasing educational and informative articles throughout the season about allergies and how weather can affect pollen, mold or air quality levels. An estimated 25% of Canadians suffer from seasonal allergies.

“The Allergy Outlook report provides allergy sufferers with the information they need to know in one convenient place, while at home or on the go,” commented Martin Belanger, director of content and product management for The Weather Network and MétéoMédia. “The visual graphs and detailed legend are comprehensive and will help our users get the most out of their day.”

In 2015, GSK Consumer Healthcare and The Weather Channel teamed up to provide the Allergy Tracker, a Flonase-branded online tool that offers an outdoor allergy tracker showing levels and maps for mold, various types of pollen and a breathing index. Flonase Allergy Relief became available over the counter in the United States in 2015.


EMC_728x90

INNOV_728x90_8-1-17

Comments are closed.